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Background: Sedentary lifestyles are now becoming a major concern for governments of developed and
developing countries with physical inactivity related to increased all-cause mortality, lower quality of life, and
increased risk of obesity, diabetes, hypertension and many other chronic diseases. The powerful onboard
computing capacity of smartphones, along with the unique relationship individuals have with their mobile phones,
suggests that mobile devices have the potential to influence behavior. However, no previous trials have been
conducted using smartphone technology to promote physical activity. This project has the potential to provide
robust evidence in this area of innovation. The aim of this study is to evaluate the effectiveness of a smartphone
application as an intervention to promote physical activity in primary care.
Methods/design: A two-group, parallel randomized controlled trial (RCT) with a main outcome measure of mean
difference in daily step count between baseline and follow up over eight weeks. A minimum of 80 active android
smartphone users over 16 years of age who are able to undertake moderate physical activity are randomly assigned
to the intervention group (n = 40) or to a control group (n = 40) for an eight week period. After randomization, all
participants will complete a baseline period of one week during which a baseline mean daily step count will be
established. The intervention group will be instructed in the usability features of the smartphone application, will be
encouraged to try to achieve 10,000 steps per day as an exercise goal and will be given an exercise promotion
leaflet. The control group will be encouraged to try to walk an additional 30 minutes per day along with their
normal activity (the equivalent of 10,000 steps) as an exercise goal and will be given an exercise promotion leaflet.
The primary outcome is mean difference in daily step count between baseline and follow-up. Secondary outcomes
are systolic and diastolic blood pressure, resting heart rate, mental health score using HADS and quality of life score
using Euroqol. Randomization and allocation to the intervention and groups will be carried out by an independent
researcher, ensuring the allocation sequence is concealed from the study researchers until the interventions are
assigned. The primary analysis is based on mean daily step count, comparing the mean difference in daily step
count between the baseline and the trial periods in the intervention and control groups at follow up.
Trial registration: Current Controlled Trials ISRCTN99944116
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Sedentary and physically inactive lifestyles are now be-
coming a major concern for governments of developed,
and indeed, developing countries worldwide. Physical in-
activity has been related to increased all-cause mortality,
to lower quality of life, and to a higher risk of obesity,
diabetes, hypertension, coronary heart disease, osteopor-
osis, fractures, colon cancer, breast cancer, prostate can-
cer, psychiatric disorders and an overall higher risk of
hospitalization [1]. While the pathological effects and re-
ductions in quality of life are of concern, so too are the
associated economic costs for health services already
working at capacity. According to the World Health Or-
ganisation, obesity rates have doubled since 1980 [2] and
in addition, physical activity rates have fallen [3]. Of all
types of physical activity, walking is the most commonly
encouraged and most commonly reported form of leisure
physical activity [4]. Evidence suggests that there are sev-
eral requirements to successfully promote an increase in
physical activity. Biofeedback is required on activity rates
such as might be provided by a pedometer, realistic goal
setting is required and lastly there must be motivation to
undertake this change in behavior [4-6]. The powerful
on-board computing ability of the smartphone has the
ability to meet these requirements, with live feedback on
activity measured as a step count as well as the ability to
goal-set and provide a system of rewards for goals
achieved. This system of live feedback is based on the use
of accelerometers. Accelerometers are small single or
uniaxial devices commonly found in all smartphones as
well as electronics such as the Nintendo Wii controller
and iPad (for example, they are the device responsible for
rotating the screen from landscape to portrait). Acceler-
ometers are an ideal choice for evaluating variability of
movement and balance providing a non-invasive, port-
able method of measurement [7]. Pedometers containing
accelerometers are well established as an acceptable form
of monitoring and have been shown to be successful in
promoting physical activity [8]. The advantage of using a
smartphone with accelerometer-enabled application is
that no additional piece of technology (that is, the ped-
ometer) is required and people generally carry their mo-
bile phone devices on their persons continuously. By
carrying the smartphone throughout the day, with an
appropriate application installed, physical activity is
recorded and displayed as a daily step count. The satur-
ation of smartphones within the mobile market (as of
February 2012, 49% of US citizens had migrated to
smartphones [9]), increases the potential benefit of, and
ability to disseminate, using such persuasive technologies
to monitor physical activity.
As far as the authors are aware after a systematic re-
view of the literature [10], no previous trials have been
conducted using a smartphone application to promotephysical activity in any setting. Despite the rapid pe-
netration of smartphones into the market place and
the ready availability of multiple applications promoting
physical activity, and indeed other health related out-
comes, there remains little evidence for the effectiveness
of such technologies. The results of a number of on-
going RCTs in the use of smart phone applications to
promote health outcomes including the current trial,
should begin to build an evidence base around the use
of smartphone applications in the promotion of physical




The study is taking place in the West of Ireland with
recruitment in the community by the North Clare Pri-
mary Care Team (PCT). This is a rural based primary
healthcare organization involving three family medicine
centers and a population of approximately 8,000 patients.
The study is coordinated by the Discipline of General
Practice at the National University of Ireland, Galway, col-
laborating with the National Centre for Biomedical Engin-
eering and Science and the Health Research Board
Clinical Research Facility. All data collection, including
the baseline screening and follow-up tests, occur in a
community setting.
Hypothesis
The formal null hypothesis to be tested in this study is
that there is no change in mean daily step count be-
tween baseline and follow-up amongst participants in
the intervention and control groups. The alternative hy-
pothesis is that the intervention group using the smart-
phone application will show a significant increase in
mean daily step count between baseline and follow-up in
comparison to the control group.
Sample size and power calculation
The sample size required for the proposed RCT is 80 par-
ticipants. The sample size is based on the following as-
sumptions. Assuming that the mean daily step count at
baseline is 4,700 steps, it is estimated that over the length
of the trial, the mean step count in the control arm will re-
duce by 470 (a 10% reduction) and increase by 940 (a 20%
improvement) amongst those receiving the intervention
[11]. Using a two-sample comparison of the mean im-
provement between the arms, a sample size of 33 subjects
per arm is required to have 80% power at the 0.05 signifi-
cance level to detect a difference in the mean improve-
ment of 1,410 between the arms, with an estimated
standard deviation of the improvement in step count of
2,000. To account for dropouts or loss of patients to
follow-up, the sample size will be adjusted upward from
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according to the intention-to-treat principle.
Participants: recruitment and eligibility
Potential participants are referred to the trial team by
their primary health care professional or they can self
refer. Eligible participants are invited to attend a screen-
ing meeting with two members of the research team. A
research engineer ensures that the potential participant
has the appropriate mobile device (Android smartphone)
and the ability to use it, and will record details of the
technology being used and smartphone literacy. A re-
search nurse ensures that the potential participant can
undertake moderate exercise in the form of walking and
then obtains informed consent from each participant.
The research nurse then conducts the screening assess-
ment by collecting relevant baseline clinical, anthropo-
metric and psychological data as described in Table 1.
After obtaining a written informed consent, they are
randomized to intervention or control. The recruitment
process is anticipated to span 12 months, from August
2012 to August 2013. The flow chart in Figure 1 represents
the movement of a participant through the stages of re-
cruitment to the study.
Eligibility for the study is determined using the follow-
ing criteria:
Inclusion criteria:
participants are adults in the community with the fol-
lowing characteristics:
1. over the age of 16 years
2. active Android smartphone usersTable 1 Secondary outcomes: definitions and measurement t
Secondary outcomes recorded at
baseline and follow-up
Definitions and measurement
Systolic blood pressure (SBP) Mean difference in mean SBP b
measure blood pressure using t
nurse will initially measure bloo
from the arm with the highest i
after initial rest of five minutes.
monitor if arm circumference is
circumference is greater than 17
Diastolic blood pressure (SBP) Mean difference in mean DBP b
measure blood pressure using t
blood pressure in both arms, an
highest initial diastolic reading.
minutes. Blood pressure will be
circumference is 17 inches or le
greater than 17 inches. These d
Resting heart rate Four readings will be recorded
blood pressure as described abo
be calculated as mean of the la
Body mass index (BMI) Height in cm and weight in kg w
Psychological evaluation a. Mental health score will be as
b. Quality of life will be assessedExclusion criteria:
at the time of recruitment, individuals with the follow-
ing characteristics are deemed ineligible to participate in
the study:
1. non Android smartphone users
2. acute psychiatric illness
3. pregnant women
4. participants who cannot undertake moderate
exercise
Randomization process
The randomization process in this RCT uses random per-
muted blocks to ensure similar numbers of participants in
the intervention and control groups.. In advance of parti-
cipant recruitment, an independent researcher is respon-
sible for generating the allocation sequence using the free
computer software program, www.randomization.com. The
same independent researcher is responsible for assigning
participants to the intervention and control groups. Thus,
the allocation sequence is concealed from all study re-
searchers until the interventions are assigned.
Description of interventions/comparison groups
The study is a two-group, parallel randomized controlled
trial. As such, following the screening visit, eligible par-
ticipants are randomly assigned to the intervention and
control groups in an equal ratio of 1:1. All participants
have the smartphone application downloaded free of
charge onto their smartphone but not made visible to the
user. For the following week after the screening visit
(baseline week), all participants are asked to carry theirechniques
s
etween baseline and follow-up: the research nurse will be trained to
he current British Hypertensive Society (BHS) guidelines. Specifically, the
d pressure in both arms, and then take the mean of three measurements
nitial diastolic reading. All measurements will be taken one minute apart
Blood pressure will be measured using an Omron I-C10 (HEM 7070) arm
17 inches or less or an Omron R7 (HEM 637) wrist monitor if arm
inches. These devices have been independently validated [12].
etween baseline and follow-up: the research nurse will be trained to
he current BHS guidelines. Specifically, the nurse will initially measure
d then take the mean of three measurements from the arm with the
All measurements will be taken one minute apart after initial rest of five
measured using an Omron I-C10 (HEM 7070) arm monitor if arm
ss or an Omron R7 (HEM 637) wrist monitor if arm circumference is
evices have been independently validated [12].
for resting heart rate from the automated devices used to measure
ve. The first reading will be ignored and the mean resting heart rate will
st three readings.
ill be recorded. BMI will be calculated as weight in kg/(height in cm) [2].
sessed using the HADS depression scale.
using the EQ-5D and the EQ-VAS.
Figure 1 Participant flow through recruitment process.
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ate at their normal physical activity levels. All partici-
pants are then contacted by SMS and mobile phone at
the end of baseline week and asked to Email their base-
line step count data to the research team using a ‘share
data’ function within the smartphone application.
Once baseline week data collection is completed, those
assigned to the intervention group are instructed on how
to turn on the smartphone application display (Figure 2)
and how to position the display widget on the smartphone
home screen. Intervention group participants receive a
short instruction by phone on the usability features of
the smartphone application settings, feedback graphs
(Figure 3), and continuous feedback on their daily step
count. Intervention group participants are encouraged to
interact with the smartphone application and are encour-
aged to try to achieve the physical activity goal of 10,000
steps per day. They are also issued with the Irish Heart
Foundation ‘Be Active’ physical activity promotionbrochure [13] by Email. Intervention group participants
are then contacted after two weeks and at the end of the
of the follow-up period by SMS and mobile phone, and
asked to forward, using a ‘share data’ function within the
smartphone application, all daily step count data up to
that point. Finally they are instructed to keep their phone
charged and to always carry it during walking hours.
Once baseline week data collection is completed, those
assigned to the control group are encouraged to try to
walk an additional 30 minutes per day along with their
normal activity (the equivalent of 10,000 steps) [14] as an
exercise goal. They are also issued with the Irish Heart
Foundation ‘Be Active’ physical activity promotion bro-
chure [13] by post or Email. Control group participants
will then be contacted after two weeks and at the end of
the of the follow-up period by SMS and mobile phone
and are asked to forward, using a ‘share data’ function
within the smartphone application, all daily step count
data up to that point. Finally they are instructed to keep
Figure 2 Home display page in smartphone application. Figure 3 Chart display of daily step counts in smartphone
application.
Glynn et al. Trials 2013, 14:157 Page 5 of 7
http://www.trialsjournal.com/content/14/1/157their phone charged and to always carry it during walk-
ing hours.
Choice and description of the smartphone application
The team of researchers trialed various smartphone appli-
cations in an attempt to source a suitable autonomous,
literacy-friendly and simple to use application, which pos-
sessed the key attributes that had already been identified
in previous work [15], as important in applications which
are designed to promote physical activity [16]. With evi-
dence in literature on the benefits of using pedometers for
promoting physical activity and walking interventions [4],
researchers combined a list of potentially suitable iPhone
and Android pedometer applications. As the Android op-
erating system allowed the application to run continuously
with or without interaction by the user it was decided to
focus on the Android platform only. After pilot testing,
the smartphone application Accupedo by Corusan [17]
was chosen for study as it provided the most comprehen-
sive list of advantages in applications of this type. These
advantages include: easy to download; user-friendly; livefeedback of step count to user; visually appealing graphic
display of step count history with goal setting and goal
achievement feedback; data sharing ability; inexpensive
(once off purchase fee of €3.29 per user) and finally the
application can run autonomously in the background,
allowing researchers to monitor activity without user
interaction or effort. At the time the trial began this
smartphone application was only available on Android
smartphone platforms. Accupdeo is now available on An-
droid and iPhone platforms.
Outcomes
The primary outcome variable is step count, measured
daily for a week prior to treatment assignment (that is,
baseline) and subsequently for a seven week follow-up
period. Seven secondary outcomes will be measured at
baseline and at the end of the follow-up period, namely:
systolic blood pressure; diastolic blood pressure; resting
heart rate; BMI; mental health as measured by HADS
score; quality of life as measured by ED-5D and EQ-VAS.
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niques for each of these secondary outcomes.
Analysis plan
Daily step count (primary outcome variable) will be col-
lected longitudinally as described above. All participants
will also be invited back for follow-up testing (secondary
outcome variables) within one week of finishing the trial.
At this follow-up visit, to evaluate the effects of the trial
on the secondary outcome measures, data on the same
clinical, anthropometric and psychological variables mea-
sured at baseline (systolic blood pressure, diastolic blood
pressure, resting heart rate, BMI, mental health as mea-
sured by HADS score, quality of life as measured by ED-
5D and EQ-VAS) will be collected.
Baseline data will be compared across the two arms
using suitable numerical summaries and graphical tech-
niques. Functional data analysis techniques, using P-spline
smoothers, will be used to graphically represent the eight
week daily changes in step count in order to identify a
suitable weekly summary statistic.
The effectiveness of the intervention will be assessed
using a linear mixed model to compare the change in the
primary outcome (within subjects and between treat-
ments) when measured as the mean, median and total
weekly steps while adjusting for the following covariates
as appropriate: baseline step count, age, gender, socioeco-
nomic status as measured by “medical card eligibility”,
BMI, mean systolic blood pressure, mean diastolic blood
pressure, mean resting heart rate, mental health as mea-
sured by HADS score, quality of life as measured by ED-
5D and EQ-VAS and smartphone literacy as measured by
whether the participant had activated Email on their
smartphone. Those below a certain income level (for ex-
ample, $238/€184 per week net income for a single person
aged up to 65 years who is living alone or $261/€202 per
week net income for a single person aged 66 years and
over who is living alone) [18] are said to be ‘medical card
eligible’ which allows access to family doctor or general
practitioner (GP) services, community health services,
dental services, prescription medicine costs, hospital care
and a range of other benefits free of charge. Therefore,
medical card eligibility provides socioeconomic data mea-
sured atan individual level. The selection of explanatory
variables for inclusion in the final model will be based on
a combination of clustering, tree-based methods and vari-
able selection techniques.
It will be assumed that missing data are missing at ran-
dom and therefore accounted for in the mixed model. The
validity of this assumption will be investigated by looking
at the missing data patterns and by modeling the probabil-
ity of missing data based on the explanatory variables
available. The sensitivity of the final conclusions to this as-
sumption will be assessed using multiple imputations viachained equations and predictive mean matching assum-
ing data are missing not at random. Model checking will
be performed using suitable model diagnostics and re-
sidual plots. All statistical analyses will be performed using
the software packages SPSS version 21.0, R version 2.14.3
and Minitab version 16.2.
Qualitative analysis
Following the RCT, qualitative research will be under-
taken to explore the perceptions, views and experiences
of participants in the randomized controlled trial, com-
paring intervention and control groups. This work in-
cludes an exploration of the barriers and facilitators to
making and maintaining lifestyle changes, as well as to
the implementation of a physical activity program in the
community generally. Toward this end, semi-structured,
one-to-one interviews will be conducted with approxi-
mately 20 participants, from the intervention and con-
trol groups, within two months of completion of the
trial. Participants will be purposively selected to ensure
that a representative range of characteristics such as age,
gender, socioeconomic status, baseline activity, BMI and
smartphone literacy at the time of recruitment are taken
into account. All interviews will be recorded and tran-
scribed; data analysis will be based on themes derived
from the transcripts. NVivo version 10, a qualitative re-
search software package, will be used to facilitate quali-
tative data management and analysis.
Ethical approval
Ethical approval was obtained from the Clinical Research
Ethics Committee, Galway University Hospitals (refer-
ence number CA 760; date 14 August 2012).
Trial status
Enrolment into the study started on 15 August 2012. Re-
cruitment is expected to be complete by July 2013.
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